Precision Biosciences Inc SEC filings DTIL
Precision Biosciences Inc has 606 filings in SEC EDGAR's recent list, going back to Mar 15, 2006. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (other events). The company's fiscal year ends on May 21.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 8, 2026 | — |
| DEF 14A | Proxy statement | Apr 8, 2026 | May 21, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2026 | May 21, 2026 |
| DEFA14A | Additional proxy material | Apr 15, 2025 | — |
| DEF 14A | Proxy statement | Apr 15, 2025 | May 28, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2025 | May 28, 2025 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 4, 2024 |
| DEFA14A | Additional proxy material | Jan 12, 2024 | — |
| DEFA14A | Additional proxy material | Dec 4, 2023 | — |
| DEF 14A | Proxy statement | Dec 4, 2023 | Jan 18, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 22, 2023 | Jan 18, 2024 |
| DEFA14A | Additional proxy material | Mar 23, 2023 | — |
| DEF 14A | Proxy statement | Mar 23, 2023 | May 4, 2023 |
| DEFA14A | Additional proxy material | Mar 29, 2022 | — |
| DEF 14A | Proxy statement | Mar 29, 2022 | May 10, 2022 |
| DEF 14A | Proxy statement | Apr 12, 2021 | May 10, 2021 |
| DEFA14A | Additional proxy material | Mar 27, 2020 | — |
| DEF 14A | Proxy statement | Mar 27, 2020 | May 13, 2020 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- DTIL (Nasdaq)
- Fiscal year ends
- May 21
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1357874
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.